Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-17-032787
Filing Date
2017-05-15
Accepted
2017-05-15 16:11:10
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 a17-12986_1s3a.htm S-3/A 400596
2 EX-4.1 a17-12986_1ex4d1.htm EX-4.1 561215
3 EX-4.2 a17-12986_1ex4d2.htm EX-4.2 578929
4 EX-4.3 a17-12986_1ex4d3.htm EX-4.3 581413
5 EX-5.1 a17-12986_1ex5d1.htm EX-5.1 53529
6 EX-5.2 a17-12986_1ex5d2.htm EX-5.2 24196
7 EX-23.1 a17-12986_1ex23d1.htm EX-23.1 4167
8 GRAPHIC g129861bci001.jpg GRAPHIC 7004
  Complete submission text file 0001104659-17-032787.txt   2214803
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

EIN.: 000000000
Type: S-3/A | Act: 33 | File No.: 333-216701 | Film No.: 17844300
SIC: 2834 Pharmaceutical Preparations